Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Ingle

Showing results (131-140 of 162) with videos related to

Pageof 17
Sort By:
Cancer|May 1, 1994
Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancerJ N Ingle, J F Foley, J A Mailliard, et al.
Cancer|July 15, 1997
A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinomaJ N Ingle, P A Johnson, V J Suman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Randomized clinical trial of tamoxifen alone or combined with fluoxymesterone in postmenopausal women with metastatic breast cancerJ N Ingle, D I Twito, D J Schaid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1986
Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancerJ N Ingle, J E Krook, S J Green, et al.
Cancer|July 1, 1991
A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the North Central Cancer Treatment Group and Mayo ClinicJ N Ingle, J A Mailliard, D J Schaid, et al.
Mayo Clinic Proceedings|June 1, 1994
Breast conservation therapy for invasive breast cancer: a review of prior trials and the Mayo Clinic experienceT M Pisansky, M Y Halyard, A L Weaver, et al.
Cancer Treatment Reports|April 1, 1985
Randomized clinical trial of cyclophosphamide, 5-FU, and prednisone with or without tamoxifen in postmenopausal women with advanced breast cancerJ E Krook, J N Ingle, S J Green, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
Randomized trial of observation versus adjuvant therapy with cyclophosphamide, fluorouracil, prednisone with or without tamoxifen following mastectomy in postmenopausal women with node-positive breast cancerJ N Ingle, L K Everson, H S Wieand, et al.
American Journal of Clinical Oncology|December 1, 1989
Randomized trial of doxorubicin alone or combined with vincristine and mitomycin C in women with metastatic breast cancerJ N Ingle, J A Mailliard, D J Schaid, et al.
Cancer|February 15, 1991
Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysisJ N Ingle, D I Twito, D J Schaid, et al.
Pageof 17

Showing results (131-140 of 162) with videos related to

Sort By:
Pageof 17
Cancer|May 1, 1994
Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancerJ N Ingle, J F Foley, J A Mailliard, et al.
Cancer|July 15, 1997
A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinomaJ N Ingle, P A Johnson, V J Suman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Randomized clinical trial of tamoxifen alone or combined with fluoxymesterone in postmenopausal women with metastatic breast cancerJ N Ingle, D I Twito, D J Schaid, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1986
Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancerJ N Ingle, J E Krook, S J Green, et al.
Cancer|July 1, 1991
A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the North Central Cancer Treatment Group and Mayo ClinicJ N Ingle, J A Mailliard, D J Schaid, et al.
Mayo Clinic Proceedings|June 1, 1994
Breast conservation therapy for invasive breast cancer: a review of prior trials and the Mayo Clinic experienceT M Pisansky, M Y Halyard, A L Weaver, et al.
Cancer Treatment Reports|April 1, 1985
Randomized clinical trial of cyclophosphamide, 5-FU, and prednisone with or without tamoxifen in postmenopausal women with advanced breast cancerJ E Krook, J N Ingle, S J Green, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1988
Randomized trial of observation versus adjuvant therapy with cyclophosphamide, fluorouracil, prednisone with or without tamoxifen following mastectomy in postmenopausal women with node-positive breast cancerJ N Ingle, L K Everson, H S Wieand, et al.
American Journal of Clinical Oncology|December 1, 1989
Randomized trial of doxorubicin alone or combined with vincristine and mitomycin C in women with metastatic breast cancerJ N Ingle, J A Mailliard, D J Schaid, et al.
Cancer|February 15, 1991
Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysisJ N Ingle, D I Twito, D J Schaid, et al.
Pageof 17